Detalhe da pesquisa
1.
Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues.
Gastroenterology
; 155(2): 479-489.e7, 2018 08.
Artigo
Inglês
| MEDLINE | ID: mdl-29655834
2.
Long-Lasting Exceptional Radiological Complete Response after Treatment with Eribulin in a Patient with Triple-Negative Breast Cancer with Liver Involvement.
Oncology
; 94 Suppl 1: 6-9, 2018.
Artigo
Inglês
| MEDLINE | ID: mdl-30036862
3.
Sunitinib in patients with pre-treated pancreatic neuroendocrine tumors: A real-world study.
Pancreatology
; 18(2): 198-203, 2018 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-29361429
4.
Everolimus in Combination with Octreotide Long-Acting Repeatable in a First-Line Setting for Patients with Neuroendocrine Tumors: A 5-Year Update.
Neuroendocrinology
; 106(4): 307-311, 2018.
Artigo
Inglês
| MEDLINE | ID: mdl-28743120
5.
Everolimus in combination with octreotide long-acting repeatable in a first-line setting for patients with neuroendocrine tumors: an ITMO group study.
Cancer
; 120(16): 2457-63, 2014 Aug 15.
Artigo
Inglês
| MEDLINE | ID: mdl-24752410
6.
Real-World Evaluation of the Management, Treatment Pathways and Outcome of Melanoma Patients with Target Therapies in Italy.
Adv Ther
; 40(9): 3875-3895, 2023 09.
Artigo
Inglês
| MEDLINE | ID: mdl-37368101
7.
Pitfalls in the diagnosis of neuroendocrine tumors: atypical clinical and radiological findings as cause of medical mistakes.
Tumori
; 95(4): 501-7, 2009.
Artigo
Inglês
| MEDLINE | ID: mdl-19856664
8.
The role of Geriatric screening tool (G8) in predicting side effect in older patients during therapy with aromatase inhibitor.
J Geriatr Oncol
; 10(2): 356-358, 2019 03.
Artigo
Inglês
| MEDLINE | ID: mdl-30333087
9.
A classification prognostic score to predict OS in stage IV well-differentiated neuroendocrine tumors.
Endocr Relat Cancer
; 25(6): 607-618, 2018 06.
Artigo
Inglês
| MEDLINE | ID: mdl-29559553
10.
Pulmonary carcinoid tumours: indolent but not benign.
Oncology
; 73(3-4): 162-8, 2007.
Artigo
Inglês
| MEDLINE | ID: mdl-18418008
11.
Safety and activity of sorafenib in different histotypes of advanced renal cell carcinoma.
Oncology
; 73(3-4): 204-9, 2007.
Artigo
Inglês
| MEDLINE | ID: mdl-18418013
12.
Are capecitabine and oxaliplatin (XELOX) suitable treatments for progressing low-grade and high-grade neuroendocrine tumours?
Cancer Chemother Pharmacol
; 59(5): 637-42, 2007 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-16937105
13.
Merkel cell carcinoma after liver transplantation: a case report.
Tumori
; 93(3): 323-6, 2007.
Artigo
Inglês
| MEDLINE | ID: mdl-17679476
14.
Renal cell cancer and sorafenib: skin toxicity and treatment outcome.
Tumori
; 93(2): 201-3, 2007.
Artigo
Inglês
| MEDLINE | ID: mdl-17557570
15.
Safety and efficacy of two different doses of capecitabine in the treatment of advanced breast cancer in older women.
J Clin Oncol
; 23(10): 2155-61, 2005 Apr 01.
Artigo
Inglês
| MEDLINE | ID: mdl-15710946
16.
Kit protein (CD117) and proliferation index (Ki-67) evaluation in well and poorly differentiated neuroendocrine tumors.
Tumori
; 92(6): 531-5, 2006.
Artigo
Inglês
| MEDLINE | ID: mdl-17260495
17.
Neuroendocrine tumors of the larynx: a clinical report and literature review.
Tumori
; 92(1): 72-5, 2006.
Artigo
Inglês
| MEDLINE | ID: mdl-16683387
18.
Perspectives in the development of novel treatment approaches.
Tumori
; 96(5): 858-73, 2010.
Artigo
Inglês
| MEDLINE | ID: mdl-21302643
19.
Case report of synchronous multicentric osteosarcoma and review of the literature: the importance of autopsy for diagnosis.
Tumori
; 91(1): 90-2, 2005.
Artigo
Inglês
| MEDLINE | ID: mdl-15850014
20.
Update on the treatment of neuroendocrine tumors.
Expert Rev Anticancer Ther
; 3(5): 631-42, 2003 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-14599087